Journal rankings · indicator year 2023
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2023
Hematology journal rankings 2023
84 ranked journals · Subfield in Medicine
Hematology has 84 ranked journals in 2023. The median OJR fell 0.06 on 2022 to 0.63, below the world average of 1.00; Q1 starts at OJR 1.06. The top three are The Lancet Haematology, Blood, and Leukemia.
Ranks and citation indicators: 2023. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2020–2022, the window the 2023 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery993
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health313
- Cardiology and Cardiovascular Medicine293
- Infectious Diseases259
- Oncology245
- Epidemiology199
- Neurology174
- Physiology161
- Radiology, Nuclear Medicine and Imaging161
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health144
- Hematology84
Show all 42 subfields
- Orthopedics and Sports Medicine124
- Ophthalmology105
- Pediatrics, Perinatology and Child Health99
- Dermatology97
- Obstetrics and Gynecology90
- Rheumatology67
- Nephrology65
- Reproductive Medicine56
- Complementary and alternative medicine54
- Pharmacology52
- Emergency Medicine44
- Geriatrics and Gerontology38
- Rehabilitation35
- Otorhinolaryngology34
- Hepatology32
- Pathology and Forensic Medicine29
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine22
- Genetics22
- Anesthesiology and Pain Medicine14
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
84 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2022. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2020–2022, the window the 2023 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2020–2022 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2014 to 2023. | Compare |
|---|---|---|---|---|---|---|---|
1The Lancet HaematologyElsevier BV · Netherlands | 3.25Q1 | 8.61 4.42 down from 2022 | 410 | 30% | $7,280 | ||
2BloodElsevier BV · United States | 3.01Q1 | 8.99 1.20 down from 2022 | 2,495 | 53% | $5,500 | ||
3LeukemiaSpringer Nature · United Kingdom | 2.96Q1 | 10.32 1.41 up from 2022 | 1,011 | 75% | $5,190 | ||
4Blood Cancer JournalOASpringer Nature · United Kingdom | 2.77Q1 | 8.61 1.00 down from 2022 | 485 | 100% | $5,290 | ||
5Blood Cancer DiscoveryAmerican Association for Cancer Research · United States | 2.41Q1 | 8.31 0.13 down from 2022 | 142 | 46% | — | ||
6Blood ReviewsElsevier BV · United Kingdom | 2.34Q1 | 6.46 1.14 down from 2022 | 208 | 48% | $5,220 | ||
7Blood AdvancesOAElsevier BV · United States | 2.26Q1 | 6.47 1.36 down from 2022 | 2,098 | 100% | $3,800 | ||
8Journal of Thrombosis and HaemostasisElsevier BV · United Kingdom | 2.22Q1 | 5.16 5.82 down from 2022 | 1,034 | 100% | $3,750 | ||
9American Journal of HematologyWiley · United States | 1.90Q1 | 5.40 1.65 down from 2022 | 993 | 92% | $5,450 | ||
10Seminars in HematologyElsevier BV · United States | 1.62Q1 | 5.90 1.75 up from 2022 | 83 | 43% | $4,070 | ||
11HematologyAmerican Society of Hematology · United States | 1.54Q1 | 3.85 0.13 down from 2022 | 278 | 100% | — | ||
12HaematologicaOAFerrata Storti Foundation · Italy | 1.47Q1 | 3.82 1.55 down from 2022 | 1,204 | 100% | $2,157 | ||
13AnemiaOAHindawi Publishing Corporation · United Kingdom | 1.32Q1 | 3.33 0.48 down from 2022 | 48 | 100% | $1,100 | ||
14Therapeutic Advances in HematologyOASAGE Publishing · United Kingdom | 1.27Q1 | 3.62 0.14 down from 2022 | 175 | 100% | $2,650 | ||
15Current Hematologic Malignancy ReportsSpringer Science+Business Media · United States | 1.25Q1 | 3.49 0.04 down from 2022 | 130 | 34% | $3,790 | ||
16Current Opinion in HematologyLippincott Williams & Wilkins · United States | 1.22Q1 | 3.26 0.36 down from 2022 | 153 | 45% | — | ||
17Pediatric RheumatologyOABioMed Central · United Kingdom | 1.19Q1 | 3.34 0.34 up from 2022 | 366 | 100% | $3,090 | ||
18Transfusion Medicine ReviewsElsevier BV · United States | 1.14Q1 | 2.71 2.82 down from 2022 | 93 | 42% | $3,970 | ||
19Research and Practice in Thrombosis and HaemostasisOAElsevier BV · United States | 1.14Q1 | 3.01 1.07 down from 2022 | 502 | 100% | $2,250 | ||
20Transplantation and Cellular TherapyElsevier BV · Netherlands | 1.10Q1 | 3.65 0.14 up from 2022 | 1,016 | 100% | $3,650 | ||
21British Journal of HaematologyWiley · United Kingdom | 1.06Q1 | 3.37 0.76 down from 2022 | 1,967 | 76% | $5,190 | ||
22HemaSphereOAWolters Kluwer · United States | 1.06Q2 | 3.43 0.19 up from 2022 | 399 | 100% | $2,480 | ||
23Bone Marrow TransplantationSpringer Nature · United Kingdom | 1.01Q2 | 3.06 0.25 down from 2022 | 1,006 | 54% | $4,990 | ||
24Best Practice & Research Clinical HaematologyElsevier BV · United Kingdom | 0.97Q2 | 2.48 0.11 down from 2022 | 130 | 35% | $3,730 | ||
25PlateletsOAInforma · United Kingdom | 0.96Q2 | 2.83 0.80 down from 2022 | 376 | 100% | $2,970 | ||
26HaemophiliaWiley · United Kingdom | 0.95Q2 | 2.45 0.86 down from 2022 | 740 | 75% | $4,760 | ||
27Journal of Blood MedicineOADove Medical Press · New Zealand | 0.94Q2 | 2.73 0.06 up from 2022 | 241 | 100% | $2,320 | ||
28European Journal Of HaematologyWiley · United Kingdom | 0.92Q2 | 2.33 1.03 down from 2022 | 497 | 75% | $4,650 | ||
29Current Research in Translational MedicineElsevier BV · France | 0.91Q2 | 2.93 0.78 down from 2022 | 102 | 24% | $3,700 | ||
30Expert Review of HematologyTaylor & Francis · United Kingdom | 0.90Q2 | 2.60 0.69 down from 2022 | 308 | 43% | — | ||
31Seminars in Thrombosis and HemostasisThieme Medical Publishers (Germany) · United States | 0.90Q2 | 3.76 1.26 down from 2022 | 361 | 43% | — | ||
32HämostaseologieThieme Medical Publishers (Germany) · Germany | 0.88Q2 | 2.79 0.52 down from 2022 | 179 | 31% | — | ||
33Annals of Laboratory MedicineOASeoul National University · South Korea | 0.85Q2 | 2.63 0.85 down from 2022 | 283 | 100% | — | ||
34Experimental HematologyElsevier BV · United States | 0.82Q2 | 2.52 0.08 down from 2022 | 256 | 100% | $3,250 | ||
35Annals of HematologyOASpringer Science+Business Media · Germany | 0.79Q2 | 2.33 0.62 down from 2022 | 1,144 | 34% | $4,590 | ||
36Clinical Hematology InternationalOASpringer Nature · Netherlands | 0.79Q2 | 2.46 0.60 up from 2022 | 66 | 100% | — | ||
37Acta HaematologicaKarger Publishers · Switzerland | 0.75Q2 | 2.12 0.51 down from 2022 | 216 | 45% | — | ||
38Blood ResearchOASouth Korea | 0.73Q2 | 2.03 0.22 up from 2022 | 212 | 100% | $2,290 | ||
39Transfusion Medicine and HemotherapyOAKarger Publishers · Switzerland | 0.69Q2 | 1.96 0.48 down from 2022 | 142 | 100% | $1,670 | ||
40International Journal of HematologySpringer Science+Business Media · Japan | 0.68Q2 | 1.91 0.40 down from 2022 | 668 | 32% | $4,390 | ||
41HematologyOAManey Publishing · United Kingdom | 0.66Q2 | 2.18 0.15 down from 2022 | 366 | 100% | $2,557 | ||
42Mediterranean Journal of Hematology and Infectious DiseasesOAPAGEPress (Italy) · Italy | 0.63Q2 | 1.75 0.90 down from 2022 | 229 | 100% | $647 | ||
43TransfusionWiley · United States | 0.62Q3 | 2.13 0.66 down from 2022 | 1,343 | 54% | $4,100 | ||
44Leukemia ResearchElsevier BV · United Kingdom | 0.62Q3 | 1.83 0.19 down from 2022 | 410 | 13% | $3,910 | ||
45Cytometry Part B Clinical CytometryWiley · United States | 0.60Q3 | 1.81 0.67 down from 2022 | 191 | 86% | $3,800 | ||
46Clinical Lymphoma Myeloma & LeukemiaElsevier BV · United States | 0.60Q3 | 1.81 0.03 down from 2022 | 824 | 39% | $3,890 | ||
47Vox SanguinisWiley · United Kingdom | 0.59Q3 | 1.81 0.93 down from 2022 | 431 | 64% | $4,150 | ||
48International Journal of Laboratory HematologyWiley · United Kingdom | 0.57Q3 | 1.62 0.75 down from 2022 | 809 | 56% | $3,880 | ||
49Leukemia & lymphoma/Leukemia and lymphomaTaylor & Francis · Switzerland | 0.56Q3 | 1.68 0.13 down from 2022 | 1,349 | 29% | — | ||
50Journal of HematologyElmer Press Inc. · Canada | 0.55Q3 | 1.63 0.07 up from 2022 | 95 | 100% | — |
Subfields of Medicine, with Hematology highlighted.
- Surgery993
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health313
- Cardiology and Cardiovascular Medicine293
- Infectious Diseases259
- Oncology245
- Epidemiology199
- Neurology174
- Physiology161
- Radiology, Nuclear Medicine and Imaging161
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine124
- Ophthalmology105
- Pediatrics, Perinatology and Child Health99
- Dermatology97
- Obstetrics and Gynecology90
- Hematology84
- Rheumatology67
- Nephrology65
- Reproductive Medicine56
- Complementary and alternative medicine54
- Pharmacology52
- Emergency Medicine44
- Geriatrics and Gerontology38
- Rehabilitation35
- Otorhinolaryngology34
- Hepatology32
- Pathology and Forensic Medicine29
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine22
- Genetics22
- Anesthesiology and Pain Medicine14
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2023. Corpus-wide, 88.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
12 additional Hematology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2020–2022, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2023. Publication window: 2020–2022. How these summaries are calculated
- Ranked journals
- 84
- Window papers (baseline)
- 47,337 +16.5% from indicator year 2020
- Median OJR
- 0.63 -11.9% from indicator year 2020
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2020–2022 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 37 | 43 | 47 | 48 | 49 | 48 | 48 | 51 | 52 | 55 | 57 | 59 | 60 | 64 | 69 | 71 | 70 | 74 | 78 | 80 | 79 | 83 | 83 | 84 | 83 | 78 | |
| Window papers (baseline) | 15,676 | 17,554 | 18,321 | 19,931 | 20,773 | 22,160 | 23,086 | 23,968 | 25,638 | 27,756 | 31,370 | 32,535 | 33,270 | 32,125 | 33,484 | 34,476 | 35,772 | 36,578 | 37,717 | 39,004 | 40,629 | 43,037 | 45,948 | 47,337 | 47,502 | 47,302 | |
| Median OJR | 0.53 | 0.57 | 0.589 | 0.593 | 0.641 | 0.646 | 0.677 | 0.650 | 0.640 | 0.663 | 0.62 | 0.73 | 0.707 | 0.713 | 0.7205 | 0.716 | 0.7196 | 0.75 | 0.74 | 0.68294 | 0.711 | 0.682 | 0.68287 | 0.63 | 0.587 | 0.658 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.